Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis
posted on 2025-11-20, 03:31authored byM Højlund, HY Kafali, B Kırmızı, P Fusar-Poli, CU Correll, S Cortese, M Sabé, J Fiedorowicz, G Saraf, J Zein, Michael BerkMichael Berk, MI Husain, JD Rosenblat, R Rubaiyat, K Corace, S Wong, S Hatcher, M Kaluzienski, LN Yatham, A Cipriani, CJ Gosling, R Carhart-Harris, P Tanuseputro, DT Myran, N Fabiano, D Moher, LM Mayo, SG Nicholls, T White, MD Prisco, J Radua, E Vieta, KS Ladha, J Katz, AA Veroniki, M Solmi
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis